Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020

GlobalData
February 29, 2012
438 Pages - SKU: GBDT3865603
Proteins in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Proteins in Oncology Drug Pipeline Update 2014 This drug pipeline update covers proteins, excluding antibodies, as drugs for the treatment of cancer. There are today 326 companies plus partners developing 359 protein drugs in 667 developmental projects  |  read more...
USD 6,746
Neonatal Seizures Global Clinical Trials Review, H2, 2014
7/14/2014 | published by: GlobalData
Neonatal Seizures Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Neonatal Seizures Global Clinical Trials Review, H2, 2014 provides data on the Neonatal Seizures clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
Malignant Mesothelioma - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Malignant Mesothelioma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H2 2014’, provides an overview of the Malignant Mesothelioma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Malignant  |  read more...
USD 2,000
The Latest Sales Figures in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
The Latest Sales Figures in Oncology Drug Pipeline Update 2014 The Latest Sales Figures in Oncology brings together up to 5 years of sales data on top 70+ cancer drugs by country/region  |  read more...
USD 4,478
Metastatic Pancreatic Cancer - Pipeline Review, H2 2014
7/22/2014 | published by: Global Markets Direct
Metastatic Pancreatic Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H2 2014’, provides an overview of the Metastatic Pancreatic Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Endometrial Cancer - Pipeline Review, H2 2014
7/22/2014 | published by: Global Markets Direct
Endometrial Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Endometrial Cancer - Pipeline Review, H2 2014’, provides an overview of the Endometrial Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Endometrial  |  read more...
USD 2,000
Hodgkin Lymphoma - Pipeline Review, H2 2014
7/22/2014 | published by: Global Markets Direct
Hodgkin Lymphoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Hodgkin Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Hodgkin Lymphoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hodgkin  |  read more...
USD 2,000
Brain Cancer - Pipeline Review, H2 2014
7/22/2014 | published by: Global Markets Direct
Brain Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Brain Cancer - Pipeline Review, H2 2014’, provides an overview of the Brain Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Brain  |  read more...
USD 2,000
Protein Kinase Inhibitors in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Protein Kinase Inhibitors in Oncology Drug Pipeline Update 2014 Protein kinase inhibitors such as Gleevec, Iressa and Tarceva have allowed the biotechnology industry to deliver on the promise of targeted cancer drugs. However, these three successful  |  read more...
USD 6,746
RANKL Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
RANKL Signaling Pathway in Oncology Drug Pipeline Update 2014 Receptor activator of nuclear factor-kappa B ligand (RANKL) is a member of tumor necrosis factor (TNF) superfamily. It binds to Receptor activator of NF-kB (RANK) and plays  |  read more...
USD 6,746
 

SELECT A LICENSE

    Online Download  USD 6,995  
    Global Site License  USD 20,985  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!